Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...
HONG KONG--(BUSINESS WIRE)-- Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding the state’s life science and biotechnology research industry. After nearly ...
As we head into BIO 2025 in Boston, our teams are closely watching trends in biotech and how those affect financings, business development, IP protection, risk, and litigation strategy. Here are eight ...
The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...
From Left to Right: Mike Pell, Kimberly Sharp, Richie Hosein From Left to Right: Sander Read, Dale Moss, Jenn Bonine, Richie Hosein From Left to Right: Mike Pell, Miguel Harding, Dale Moss, Richie ...
The diabetes treatment landscape in India is on the brink of transformation. Innovative GLP-1 medications are set to redefine therapy standards, providing remarkable advantages in glucose regulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback